 Adrenergic beta-2 Receptor Agonists
"Adrenergic beta-2 Receptor Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS.
| Descriptor ID |
D058666
|
| MeSH Number(s) |
D27.505.519.625.050.100.200.200 D27.505.696.577.050.100.200.200
|
| Concept/Terms |
Adrenergic beta-2 Receptor Agonists- Adrenergic beta-2 Receptor Agonists
- Adrenergic beta 2 Receptor Agonists
- Adrenergic beta2-Agonists
- Adrenergic beta2 Agonists
- beta2-Agonists, Adrenergic
- Adrenergic beta-2 Agonists
- Adrenergic beta 2 Agonists
- Agonists, Adrenergic beta-2
- beta-2 Agonists, Adrenergic
- Adrenergic beta-2 Receptor Agonist
- Adrenergic beta 2 Receptor Agonist
|
Below are MeSH descriptors whose meaning is more general than "Adrenergic beta-2 Receptor Agonists".
Below are MeSH descriptors whose meaning is more specific than "Adrenergic beta-2 Receptor Agonists".
This graph shows the total number of publications written about "Adrenergic beta-2 Receptor Agonists" by people in this website by year, and whether "Adrenergic beta-2 Receptor Agonists" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 | | 2010 | 1 | 0 | 1 | | 2011 | 2 | 1 | 3 | | 2012 | 1 | 1 | 2 | | 2013 | 1 | 1 | 2 | | 2014 | 1 | 1 | 2 | | 2015 | 2 | 1 | 3 | | 2016 | 1 | 1 | 2 | | 2018 | 4 | 1 | 5 | | 2019 | 3 | 1 | 4 | | 2020 | 1 | 0 | 1 | | 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Adrenergic beta-2 Receptor Agonists" by people in Profiles.
-
Pace WD, Brandt E, Carter VA, Chang KL, Edwards CL, Evans A, Fox C, Gaona G, Han MK, Kaplan AG, Kent R, Kocks JWH, Kruszyk M, Le Lievre CE, Li Voti T, Mahle C, Make B, Ratigan AR, Shaikh A, Skolnik N, Stanley B, Yawn BP, Price DB. COPD Population in US Primary Care: Data From the Optimum Patient Care DARTNet Research Database and the Advancing the Patient Experience in COPD Registry. Ann Fam Med. 2022 Jul-Aug; 20(4):319-327.
-
Moghbeli K, Valenzi E, Naramore R, Sembrat JC, Chen K, Rojas MM, Wenzel SE, Lafyatis R, Modena B, Weathington NM. ?-Agonist exposure preferentially impacts lung macrophage cyclic AMP-related gene expression in asthma and asthma COPD overlap syndrome. Am J Physiol Lung Cell Mol Physiol. 2021 11 01; 321(5):L837-L843.
-
R Arnold N, S Wan E, Hersh CP, Schwartz A, Kinney G, Young K, Hokanson J, Regan EA, P Comellas A, Fortis S. Inhaled Medication Use in Smokers With Normal Spirometry. Respir Care. 2021 Apr; 66(4):652-660.
-
Keller T, Spece LJ, Donovan LM, Udris E, Coggeshall SS, Griffith M, Bryant AD, Casaburi R, Cooper JA, Criner GJ, Diaz PT, Fuhlbrigge AL, Gay SE, Kanner RE, Martinez FJ, Panos RJ, Shade D, Sternberg A, Stibolt T, Stoller JK, Tonascia J, Wise R, Yusen RD, Au DH, Feemster LC. Association of Guideline-Recommended COPD Inhaler Regimens With Mortality, Respiratory Exacerbations, and Quality of Life: A Secondary Analysis of the Long-Term Oxygen Treatment Trial. Chest. 2020 08; 158(2):529-538.
-
Anderson WC, Gondalia R, Hoch HE, Kaye L, Barrett M, Szefler SJ, Stempel DA. Assessing asthma control: comparison of electronic-recorded short-acting beta-agonist rescue use and self-reported use utilizing the asthma control test. J Asthma. 2021 02; 58(2):271-275.
-
Gondalia R, Bender BG, Theye B, Stempel DA. Higher short-acting beta-agonist use is associated with greater COPD burden. Respir Med. 2019 Oct - Nov; 158:110-113.
-
Wechsler ME, Szefler SJ, Ortega VE, Pongracic JA, Chinchilli V, Lima JJ, Krishnan JA, Kunselman SJ, Mauger D, Bleecker ER, Bacharier LB, Beigelman A, Benson M, Blake KV, Cabana MD, Cardet JC, Castro M, Chmiel JF, Covar R, Denlinger L, DiMango E, Fitzpatrick AM, Gentile D, Grossman N, Holguin F, Jackson DJ, Kumar H, Kraft M, LaForce CF, Lang J, Lazarus SC, Lemanske RF, Long D, Lugogo N, Martinez F, Meyers DA, Moore WC, Moy J, Naureckas E, Olin JT, Peters SP, Phipatanakul W, Que L, Raissy H, Robison RG, Ross K, Sheehan W, Smith LJ, Solway J, Sorkness CA, Sullivan-Vedder L, Wenzel S, White S, Israel E. Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma. N Engl J Med. 2019 09 26; 381(13):1227-1239.
-
Meek P, Lareau S, Fahy B, Austegard E. Medicines for COPD. Am J Respir Crit Care Med. 2019 07 15; 200(2):P3-P5.
-
Grossman NL, Doros GD, Fandino N, Fuhlbrigge AL, Pace WD, Wechsler ME, Yawn BP, Israel E. Susceptibility to exacerbations in Black adults with asthma. J Asthma. 2019 Jul; 56(7):704-710.
-
Szefler SJ, Hoch HE, Tuffli M, Gondalia R, Barrett MA, Van Sickle D, Stempel DA. Quantifying beta-agonist utilization: Occasions or puffs? J Allergy Clin Immunol Pract. 2019 03; 7(3):1088-1090.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|